Siemens Healthineers AG
XETRA:SHL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (49.9), the stock would be worth €42.01 (20% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 41.4 | €34.88 |
0%
|
| 3-Year Average | 49.9 | €42.01 |
+20%
|
| 5-Year Average | 40 | €33.64 |
-4%
|
| Industry Average | 25.4 | €21.39 |
-39%
|
| Country Average | 22 | €18.5 |
-47%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.3B EUR | 41.4 | 18.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
162.6B USD | 65.3 | 56.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
155.4B USD | 29 | 24.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
112.7B USD | 20.7 | 34.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
102.7B USD | 27.3 | 22.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
83.8B USD | 29.3 | 23.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.8B USD | 37 | 44.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.2B USD | 46 | 42.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.5B USD | 17.6 | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
29.9B USD | 17.2 | 20.1 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
204.2B CNY | 25.9 | 26.1 |
Market Distribution
| Min | 0.3 |
| 30th Percentile | 12.8 |
| Median | 22 |
| 70th Percentile | 33.7 |
| Max | 8 508.8 |
Other Multiples
Siemens Healthineers AG
Glance View
Nestled at the intersection of innovation and healthcare, Siemens Healthineers AG carries forth the legacy of its parent conglomerate, Siemens, into the realm of medical technology. Headquartered in Erlangen, Germany, Siemens Healthineers has made it its mission to transform care delivery and shape a new age of healthcare. The company leverages its extensive engineering expertise and robust R&D capabilities to design a broad spectrum of healthcare solutions that range from imaging systems and in-vitro diagnostics to advanced therapy solutions and services. Their cutting-edge imaging portfolio includes MRI, CT, and X-ray systems, which aid physicians in making precise diagnoses. By harnessing data analytics and AI, they offer tools that go beyond traditional diagnostics, enabling more personalized and efficient patient care. The crux of Siemens Healthineers' business model lies not only in selling sophisticated medical equipment but also in a substantial service component. Maintenance contracts, performance upgrades, and consulting services ensure a steady revenue stream and deepen client relationships. The company also invests in digital health services, driven by a vision to empower healthcare providers with swift, data-infused insights. Through partnerships with healthcare institutions worldwide, Siemens Healthineers develops tailored solutions that enhance operational efficiency, patient experience, and clinical outcomes. These collaborations help expand their market footprint and solidify their position as an indispensable partner in the ever-evolving healthcare landscape. In essence, Siemens Healthineers helps healthcare providers improve patient outcomes while optimizing their operational workflows, thus deriving mutual growth and success.